BET-IN-16 (Comp I) is a BET inhibitor. BET-IN-16 shows anticancer activity. BET-IN-16 inhibits prostate cancer cell growth, with IC50 values of 0.043 and 0.034 µM against LNCaP and 22Rv1 cells, respectively[1].
Molecular Weight:
515.56
CAS Number:
[2089390-09-8]
Formula:
C31H25N5O3
Target:
Epigenetic Reader Domain
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted